Overcoming Endocrine Resistance in Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Trials Related to Fulvestrant
Related studies linked through entity extraction aliases.
Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alobresib (Formerly GS-5829) in Adults With Advanced Solid Tumors and Lymphomas and in Combination With Exemestane or Fulvestrant in Adults With Estrogen Receptor Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Study of the Combination of MLN9708 and Fulvestrant
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Palbociclib in Combination With Fulvestrant or Tamoxifen as Treatment for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Fulvestrant as Maintenance Therapy After First-line Chemotherapy in HER2 - Postmenopausal MBC Patients
- Status
- UNKNOWN
- Phase
- PHASE3
Study to Assess the Efficacy and Safety of the Epigenetic Modifying Effects of CC-486 (Oral Azacitidine) in Combination With Fulvestrant
- Status
- TERMINATED
- Phase
- PHASE2
Detect V / CHEVENDO (Chemo vs. Endo)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase Inhibitor Therapy
- Status
- TERMINATED
- Phase
- PHASE3
A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Everolimus Beyond Progression
- Status
- TERMINATED
- Phase
- PHASE2
Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE1
A Randomized Study of AZD2014 in Combination With Fulvestrant in Metastatic or Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Endocrine Response in Women With Invasive Lobular Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Fulvestrant Combined Anastrozole Versus Anastrozole in Luminal A-like Postmenopausal ABC
- Status
- WITHDRAWN
- Phase
- PHASE2
S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE3
A Trial Comparing Docetaxel Plus Fulvestrant With Docetaxel in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
An Open Label Multi-center Extension Study to Evaluate Long-term Safety/ Tolerability of Dovitinib in Patients With Solid Tumors Who Continue to Receive Treatment With Dovitinib (TKI258) in Novartis-sponsored Single Agent Dovitinib Studies Which Fulfilled the Requirements for the Primary Objective
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Phase 2 Study of Fulvestrant With and Without Entinostat in Postmenopausal Women With ER+ Advanced Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3